Physician profile
Hans H Moosa
NPI 1194768432
$5,672.41
in general payments reported to CMS, 2019-2025
35 companies · $2,411 in 2025
The $2,411 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $352 · 2020: $355 · 2021: $991 · 2022: $559 · 2023: $674 · 2024: $331 · 2025: $2,411.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $2,011 · Food and Beverage: $1,405.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $2,010.97 |
| Food and Beverage | $1,404.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $2,059.85 | 2021-2025 | Amnioexcel Plus, Integra, Micromatrix |
| Smith+Nephew, INC. | $612.47 | 2019-2024 | Collagenase Santyl |
| Organogenesis INC. | $388.07 | 2021-2025 | Puraply Antimicrobial, Puraply, Apligraf |
| Tactile Systems Technology INC | $354.15 | 2021-2022 | |
| Bolton Medical INC | $343.41 | 2021-2024 | Treo Abdominal Stent-Graft System |
| Bard Peripheral Vascular, INC. | $294.39 | 2019-2022 | |
| Boston Scientific Corporation | $222.89 | 2021-2025 | Rotablator Rotational Atherectomy System Console Kit, Synergy, Peripheral Rotalink Plus |
| Shockwave Medical, INC | $184.27 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cardiovascular Systems INC. | $157.88 | 2020 | |
| Medtronic, INC. | $129.61 | 2021-2023 | Endurant Iis, Abre |
| Convatec INC. | $128.33 | 2021-2025 | |
| W. L. Gore & Associates, INC. | $119.14 | 2021-2024 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Viabahn Vbx Balloon Expandable Endo |
| Lemaitre Vascular, INC. | $79.66 | 2022-2023 | Artegraft Vascular Graft |
| Silk Road Medical, INC. | $69.49 | 2023-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Z-Medica, LLC | $57.37 | 2019 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hydrofera LLC | $57.20 | 2023 | Hydrofera Blue |
| Covidien LP | $44.53 | 2019 | |
| Cashflow Solutions, LLC | $36.88 | 2023-2024 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
| Abbott Laboratories | $36.17 | 2021-2022 | |
| Kerecis Limited | $33.97 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Shape Memory Medical INC. | $28.07 | 2024 | Impede Embolization Plug |
| Solventum Corporation | $26.45 | 2024 | Activ.A.C. |
| Inari Medical, INC. | $24.44 | 2020-2022 | |
| Cook Medical LLC | $21.99 | 2024 | Zilver Ptx, Icast Covered Stent System, 6mmx22mmx120cm |
| Ethicon US, LLC | $19.23 | 2024 | Enseal, Echelon; Endopath |
| Janssen Pharmaceuticals, INC | $17.94 | 2021 | |
| Teleflex LLC | $17.01 | 2023 | Guideliner |
| Misonix INC | $16.00 | 2020 | |
| Bsn Medical INC | $14.89 | 2022 | |
| Angiodynamics, INC. | $14.83 | 2022 | |
| Medtronic Vascular, INC. | $13.98 | 2020 | |
| Hartmann USA, INC. | $13.06 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $12.63 | 2021 | |
| Kci USA, INC. | $12.01 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $10.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hans Moosa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.